Risk that the company will be unable to establish partnerships with external organizations as expected, or that existing partnership relationships will change, preventing it from realizing benefits such as technology integration and fixed-cost control. Covers the formation and maintenance of broad strategic partnerships and is not limited to specific universities, pharmaceutical companies or joint research counterparties.